21/02/2015 - 22:33 HOUSTON – Babies born to mothers who took omalizumab just before or during pregnancy exhibited birth defects that are in line with the general popul... More » Visit websiteField of Interest: PulmonologyCategories: FPN || ConferencesIMN || ConferencesOBGYN || ConferencesFPN || NewsFPN || Allergy & ImmunologyFPN || Women's HealthIMN || NewsIMN || Allergy & ImmunologyNews Feed: Internal Medicine News - Pulmonology
